When was Vetherapy founded?

Vetherapy was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Vetherapy located?

Vetherapy is headquartered in San Francisco, United States.

Who is the current CEO of Vetherapy?

Pedro Carvalho of Vetherapy. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Vetherapy have?

As of Jun 30, 2026, the latest employee count at Vetherapy is 2.

Is Vetherapy a funded company?

Vetherapy is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 10, 2018.

When was the latest funding round of Vetherapy?

Vetherapy's latest funding was a $***** Grant (prize money) round on Sep 30, 2019, with participation from 1 investor. Its primary sector is Veterinary HealthTech. In United States, the Veterinary HealthTech sector has seen $125M in funding in 2026 to date.

Where does Vetherapy rank among its competitors?

Vetherapy ranks 8th amongst 20 active competitors, of which 9 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Gallant, which secured $18M in Jun, 2025.

Who are the top competitors of Vetherapy?

Vetherapy's top competitors include Gallant, Bioceltix and VetStem. Among them, Gallant secured the most recent funding round in June, 2025.

Vetherapy - 2026 Company Profile, Team, Funding & Competitors

Vetherapy is a seed company based in San Francisco (United States), founded in 2015 by Pedro Carvalho and Fernanda Berti. It operates as a Provider of stem cell therapies for pets. Vetherapy has raised $250K in funding from IndieBio. The company has 20 active competitors, including 9 that are funded. Its top competitors include companies like Gallant, Bioceltix and VetStem.

Company Details

VR therapy is developing stem cell therapies for pets. The company is focused on inflammatory, auto-immune and neurologic diseases. The company provides stem cells for dogs, cats, and horses. The company has patented wound healing hydrogel, based on stem cell secretome, that helps in the regeneration of all the layers of the skin. The company has stem cell-derived solutions in the form of eye-drops and plasma solutions.

Website: vetherapy.co
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

San Francisco, United States

Stage

Seed

Total Funding

$250K in 3 rounds

Latest Funding Round

Grant (prize money), Sep 30, 2019, $*****

Investors

IndieBio & 2 more

Ranked

8^th among 20 active competitors

Employee Count

2 as on Jun 30, 2026

Similar Companies

Gallant & 22 more

View Vetherapy's full profile

Vetherapy has raised a total funding of $250K over 3 rounds. Its first funding round was on Jan 10, 2018. Its latest funding round was a Grant (prize money) round on Sep 30, 2019 for $*****. 1 investor participated in its latest round. Vetherapy has 3 institutional investors.

Here is the list of recent funding rounds of Vetherapy:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2019	8405346	Grant (prize money)	4349222	2052669	5669406	5412079
May 01, 2019	1550598	Grant (prize money)	3866430	6581959	5289893	Europa
Jan 10, 2018	8190188	Seed	7330019	5307863	IndieBio	5259473

Access funding benchmarks and valuations. Sign up today!

View details of Vetherapy's funding rounds and investors

The founders of Vetherapy are Pedro Carvalho and Fernanda Berti. Pedro Carvalho is the CEO of Vetherapy.

Here are the details of Vetherapy's key team members:

Pedro Carvalho: Co-Founder & CEO of Vetherapy. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Fernanda Berti: Co-Founder & CSO of Vetherapy.

View details of Vetherapy's Founder profiles and Board Members

Vetherapy's employee count trend

Vetherapy has 2 employees as of Jun 26. Here is Vetherapy's employee count trend over the years:

Uncover Vetherapy's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vetherapy include Gallant, Bioceltix and VetStem. Here is the list of Top 10 competitors of Vetherapy, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gallant 2018, Los Angeles (United States), Series B	Provider of stem cell based regenerative therapy for dogs	$61.5M	Bold Capital Partners, Digitalis Ventures ... & 13 others	55/100
2nd	Bioceltix 2017, Wroclaw (Poland), Seed	Developer of drugs for veterinary therapy	-	Infini, Leonarto	48/100
3rd	VetStem 2002, Poway (United States), Unfunded	Developer of vet stem cell therapy for animal health	-	-	43/100
4th	eQcell 2010, Guelph (Canada), Series A	Developer of stem cell therapies for the treatment of animals	$4.6M	Accelerator Centre, Ag Capital Canada	37/100
5th	Vetbiobank 2011, Marcy l Étoile (France), Seed	Veterinary regenerative medicine	$450K	Angelor, Health Angels Rhone-Alpes & 4 others	36/100
6th	Animal Cell Therapies 2008, San Diego (United States), Series A	Research and development of veterinary stem cell	$10.1M	Sabes Foundation	32/100
7th	RevaTis 2013, Luxemburg (United States), Funding Raised	Provider of undifferentiated muscle-derived stem	-	Noshaq, WBC Ventures	31/100
8th	Vetherapy 2015, San Francisco (United States), Seed	Provider of stem cell therapies for pets	$250K	Europa, EIC Fund & 1 others	30/100
9th	J-ARM 2006, Osaka (Japan), Seed	Developer of lymphocyte therapy and stem cell therapy for dogs and cats	-	Japan Asia Investment, Nippon Venture Capital ... & 2 others	29/100
10th	Global Stem cell Technology 2012, Evergem (Belgium), Acqui-Hired	Developer of blood-derived mesenchymal stem cells for clinical use in animals	-	-	29/100